Most Influential Leaders Driving Innovation in Immuno-Oncology and Precision Medicine to Watch in 2026
In a time when conversations around mental health are finally moving from the margins to the mainstream, Dr. Sola Togun Butler emerges as a voice of rare depth, courage, and cultural clarity. This feature is not simply a profile of professional achievement. It is an exploration of how lived experience, heritage, and empathy can reshape systems that were never designed to serve everyone equally.
On Cover
Dr. Ramón Gutiérrez-Sandoval
Chief Scientific Officer of OGRD Alliance
In the complex landscape of precision oncology, where breakthrough therapies emerge with promising regularity, a fundamental question often goes unanswered: What happens when a patient’s immune system can no longer recognize the very threats it was designed to eliminate? While pharmaceutical innovation accelerates and cellular therapies capture headlines, Dr. Ramón Gutiérrez has spent years addressing a problem that exists beneath the surface of conventional immunotherapy: the structural collapse of immune recognition itself.


Dr. Sola Togun-Butler
Founder, CEO, Psychotherapist, & Coach
In a medical practice in Nigeria, where two doctors opened their doors to everyone regardless of their ability to pay, a young girl watched her parents rewrite the rules of healthcare. Her father, a psychiatrist, spoke openly about mental health in a society where such conversations were taboo. Her mother, a general practitioner, treated patients with dignity even when payment never came. These were not occasional acts of charity but the daily rhythm of a household where service was as natural as breathing.
Dr. Jennifer Johnston
Founder & CEO of Elle, MD Biotechnologies
In her clinical practice as a family physician, Dr. Jennifer Johnston observed a recurring theme: women expressing a desire for more contraceptive options that better suited their individual needs and lifestyles. This clinical insight, combined with her perspective as a mother of four children—three daughters—sparked the idea that would eventually become Elle, MD Biotechnologies.



